Margareth Castro Ozelo
Margareth Castro Ozelo
Adresse e-mail validée de unicamp.br
Titre
Citée par
Citée par
Année
Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response
CS Manno, GF Pierce, VR Arruda, B Glader, M Ragni, JJE Rasko, ...
Nature medicine 12 (3), 342-347, 2006
19262006
AAV-mediated factor IX gene transfer to skeletal muscle in patients with severe hemophilia B
CS Manno, AJ Chew, S Hutchison, PJ Larson, RW Herzog, VR Arruda, ...
Blood, The Journal of the American Society of Hematology 101 (8), 2963-2972, 2003
8362003
Phase 3 study of recombinant factor IX Fc fusion protein in hemophilia B
JS Powell, KJ Pasi, MV Ragni, MC Ozelo, LA Valentino, JN Mahlangu, ...
New England Journal of Medicine 369 (24), 2313-2323, 2013
2922013
Evidence of multiyear factor IX expression by AAV-mediated gene transfer to skeletal muscle in an individual with severe hemophilia B
H Jiang, GF Pierce, MC Ozelo, EV De Paula, JA Vargas, P Smith, ...
Molecular Therapy 14 (3), 452-455, 2006
2322006
An inherited mutation leading to production of only the short isoform of GATA-1 is associated with impaired erythropoiesis
LM Hollanda, CSP Lima, AF Cunha, DM Albuquerque, J Vassallo, ...
Nature genetics 38 (7), 807-812, 2006
1852006
Eradication of neutralizing antibodies to factor VIII in canine hemophilia A after liver gene therapy
JD Finn, MC Ozelo, DE Sabatino, HWG Franck, EP Merricks, JM Crudele, ...
Blood, The Journal of the American Society of Hematology 116 (26), 5842-5848, 2010
1742010
Family history as a risk factor for venous thromboembolism
S Noboa, G Le Gal, K Lacut, B Mercier, C Leroyer, E Nowak, D Mottier, ...
Thrombosis research 122 (5), 624-629, 2008
902008
Results from a large multinational clinical trial (guardian™ 1) using prophylactic treatment with turoctocog alfa in adolescent and adult patients with severe haemophilia A …
SR Lentz, M Misgav, M Ozelo, SZ Šalek, D Veljkovic, M Recht, ...
Haemophilia 19 (5), 691-697, 2013
832013
Inherited risk factors for thrombophilia among children with Legg-Calvé-Perthes disease
VR Arruda, WD Belangero, MC Ozelo, GB Oliveira, RG Pagnano, ...
Journal of Pediatric Orthopaedics 19 (1), 84-87, 1999
831999
A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A
H Matsui, C Hegadorn, M Ozelo, E Burnett, A Tuttle, A Labelle, ...
Molecular Therapy 19 (4), 723-730, 2011
772011
Frequency of platelet type versus type 2B von Willebrand disease
A Hamilton, M Ozelo, J Leggo, C Notley, H Brown, JP Frontroth, ...
Thrombosis and haemostasis 105 (03), 501-508, 2011
702011
Results from a large multinational clinical trial (guardian™ 3) using prophylactic treatment with turoctocog alfa in paediatric patients with severe haemophilia A: safety …
R Kulkarni, FA Karim, S Glamocanin, D Janic, V Vdovin, M Ozelo, ...
Haemophilia 19 (5), 698-705, 2013
662013
Key issues in inhibitor management in patients with haemophilia
K Gomez, R Klamroth, J Mahlangu, ME Mancuso, ME Mingot, MC Ozelo
Blood Transfusion 12 (Suppl 1), s319, 2014
632014
Efficacy and safety of dapsone as a second-line treatment in non-splenectomized adults with immune thrombocytopenic purpura
SMC Vancine-Califani, EV De Paula, MC Ozelo, FLA Orsi, DR Fabri, ...
Platelets 19 (7), 489-495, 2008
492008
Polymorphisms of methylenetetrahydrofolate reductase (MTHFR), methionine synthase (MTR), methionine synthase reductase (MTRR), and thymidylate synthase (TYMS) in multiple …
CSP Lima, MM Ortega, MC Ozelo, RC Araujo, CA De Souza, ...
Leukemia research 32 (3), 401-405, 2008
462008
When and how to start prophylaxis in boys with severe hemophilia without inhibitors: communication from the SSC of the ISTH
K Fischer, PW Collins, MC Ozelo, A Srivastava, G Young, VS Blanchette
Journal of Thrombosis and Haemostasis 14 (5), 1105-1109, 2016
452016
Reduction of the immune response to factor VIII mediated through tolerogenic factor VIII presentation by immature dendritic cells
M Qadura, M Othman, B Waters, R Chegeni, K Walker, A Labelle, M Ozelo, ...
Journal of thrombosis and haemostasis 6 (12), 2095-2104, 2008
452008
Long‐acting recombinant factor IX Fc fusion protein (rFIXF c) for perioperative management of subjects with haemophilia B in the phase 3 B‐LONG study
JS Powell, S Apte, H Chambost, C Hermans, S Jackson, NC Josephson, ...
British journal of haematology 168 (1), 124-134, 2015
442015
A cost evaluation of treatment alternatives for mild‐to‐moderate bleeding episodes in patients with haemophilia and inhibitors in Brazil
MC Ozelo, PR Villaça, JOSC DE ALMEIDA, TMF BUENO, ...
Haemophilia 13 (5), 462-469, 2007
432007
Choosing outcome assessment tools in haemophilia care and research: a multidisciplinary perspective
K Fischer, P Poonnoose, AL Dunn, P Babyn, MJ Manco‐Johnson, ...
Haemophilia 23 (1), 11-24, 2017
412017
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20